BRIC Inserm U1312, Université de Bordeaux, 33615 Pessac, France.
Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Rev Neurol (Paris). 2023 Jun;179(5):490-501. doi: 10.1016/j.neurol.2023.03.007. Epub 2023 Mar 22.
Glioblastoma (GB) is the most common and aggressive primary brain tumor, with poor patient survival and lack of effective therapies. Late advances trying to decipher the composition of the GB tumor microenvironment (TME) emphasized its role in tumor progression and potentialized it as a therapeutic target. Many components participate critically to tumor development and expansion such as blood vessels, immune cells or components of the nervous system. Dysmorphic tumor vasculature brings challenges to optimal delivery of cytotoxic agents currently used in clinics. Also, massive infiltration of immunosuppressive myeloid cells and limited recruitment of T cells limits the success of conventional immunotherapies. Neuronal input seems also be required for tumor expansion. In this review, we provide a comprehensive report of vascular and immune component of the GB TME and their cross talk during GB progression.
胶质母细胞瘤(GB)是最常见和侵袭性最强的原发性脑肿瘤,患者生存率低,缺乏有效治疗方法。最近的研究进展试图解析 GB 肿瘤微环境(TME)的组成,强调了其在肿瘤进展中的作用,并将其作为治疗靶点。许多成分对肿瘤的发展和扩张起着至关重要的作用,如血管、免疫细胞或神经系统的成分。畸形的肿瘤血管给目前临床上使用的细胞毒性药物的最佳输送带来了挑战。此外,大量浸润的免疫抑制性髓样细胞和 T 细胞的有限募集限制了传统免疫疗法的成功。神经元的输入似乎也是肿瘤扩张所必需的。在这篇综述中,我们全面报告了 GB TME 的血管和免疫成分及其在 GB 进展过程中的相互作用。